Shopping Cart is Empty..

$ 0

Aug 2017 | 738 Views

Buy this report from
$2765

Drug Screening Market by Product & Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers {Semiconductor Breath Analyzers, Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices, Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, Sample Collection Cups} and Laboratory Services], by Sample Type [Oral Fluid/Saliva, Breath, Hair, Other Samples {Blood & Sweat}], by End User [Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Diagnostics and Biotech	LI 171070	Pages: 212	Formats*:
Aug 2017 \| 738 Views	Charts: 58	Tables: 84	Author(s): Onkar Sumant and Gaurav Phalke

Drug Screening Market Overview:

Global Drug Screening Market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7% from 2017 to 2023. Drug screening test analyses biological samples such as blood, hair, urine; to diagnose the presence of drug of abuse or its metabolites in patient’s body. Drug screening tests are used to determine if person is under the influences of drug or if a person was under the influence of drug at a certain point of time. Drug screening devices have improved owing to introduction of new technology; offering the users precise and accurate results. Growing alcohol consumption among youth as well as elderly population, overuse of prescribed drugs, increased use of narcotics and illicit drugs is a major driver for drug screening market.

Global Drug Screening Market Segmentation

The global drug screening market is segmented based on equipment and services, sample type, end user and by geography. Based on equipment and services market is divided into immunoassay analyzers, chromatography instruments, breath analyzers; breath analyzers are further bifurcated into fuel cell breath analyzers, semiconductor breath analyzers, other devices. Based on RTD (rapid testing devices) urine testing devices, oral fluid/saliva testing devices. The urine testing devices are further classified into urine testing cups, dip cards and cassettes Based on consumables assay kits, sample collection cups, calibrators and controls, other consumables. Laboratory services hold major market share in this segment. The sample type segment is divided into urine sample, breath sample, oral fluid sample, hair sample, other sample (blood & sweat). Urines sample are widely used in this segment and draw a large amount of share in this segment. Based on end user the market is divided into workplace and school, drug testing laboratories, criminal justice and law enforcement agencies, hospitals, drug treatment centers, pain management centers, personal users.

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to overcome the effect of restraints. Increased consumption of alcohol and illicit drugs, countries establishing stringent laws and increasing government funding to control drug trafficking in states will provide excellent opportunity for drug screening devices. Immunoassay analyzers occupied the largest share in the drug screening equipment market in 2016.

Drugs Screening Equipment Market (2016)

Key players in the drug screening market include Alere, Inc., Drägerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and Express Diagnostics International Inc.

Key Benefits:

The study provides an in-depth analysis of the global drug screening market, with current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities is discussed.
Key market players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the market.
Porters Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Drug Screening Market Key Segments:

By Product & Service

Equipment
- Immunoassay Analysers
- Chromatography Instruments
- Breath Analysers
  - Fuel Cell Breathalysers
  - Semiconductor Breathalysers
  - Other Devices
Rapid Testing Devices
- Urine Testing Devices
  - Urine Testing Cups
  - Dip Cards
  - Cassettes
- Oral Fluid Testing Devices
Consumables
- Assay Kits
- Sample Collection Cups
- Calibrators and Controls
- Others
Laboratory Services

By Sample Type

Urine Sample
Breath Sample
Oral Fluid Sample
Hair Sample
Others (Blood and Sweat Samples)

By End User

Workplace and Schools
Drug Testing Laboratories
Criminal Justice System & Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Pain Management Centers
Personal Users

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

License Type

Online Only

Data Pack

Single User PDF

Five User Online/PDF

Enterprise Online/PDF

LICENSE INFO

Users/Sharing

Restricted to one authorized user

Limited to 5 authorized users

Unlimited within company / enterprise

Printing

No Print/No Copy/No Screenshot

One Print only

Up to Five Copies

Unlimited within company / enterprise

Delivery Formats

ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

Get More Information About this Report

Please input above shown text
into input box or click refresh

Have questions ?
Speak with analyst

Did you miss anything?
To add more

* Taxes/Fees, If applicable, will be
added at the checkout. All prices in USD.

Need More Information

+1-503-894-6022

help@alliedmarketresearch.com

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Report Title: Drug Screening Market by Product & Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers {Semiconductor Breath Analyzers, Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices, Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, Sample Collection Cups} and Laboratory Services], by Sample Type [Oral Fluid/Saliva, Breath, Hair, Other Samples {Blood & Sweat}], by End User [Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Select Chapters

Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8

Full Name: *:

Company Name: *:

Job Role: *:

Email: *:

Country: *:

Contact Number: *:

How can we help? *:

Security Code: *:

STAY WITH US

WE ACCEPT

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Chapter: 1 INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY 1.4.1. Primary research 1.4.2. Secondary research 1.4.3. Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY 2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW 3.1. MARKET DEFINITION AND SCOPE 3.2. KEY FINDINGS 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. PORTER’S FIVE FORCES ANALYSIS 3.4. PATENT ANALYSIS. 3.4.1. Patent analysis, by year (2010-2016) 3.4.2. Patent analysis, by region 3.5. REGULATIONS 3.6. MARKET DYNAMICS 3.6.1. Drivers 3.6.1.1. Stringent government regulations regarding drug abuse 3.6.1.2. Rise in awareness against drug abuse 3.6.1.3. Surge in funding for drug screening 3.6.2. Restraints 3.6.2.1. Consideration of drug screening as a violation of rights 3.6.2.2. Possible manipulation of drug screening tests 3.6.3. Opportunities 3.6.3.1. Development of novel drug screening tests 3.6.3.2. Tapping the emerging markets
Chapter: 4 DRUG SCREENING MARKET, BY PRODUCT & SERVICE 4.1. OVERVIEW 4.1.1. Market size and forecast 4.2. EQUIPMENT 4.2.1. Key market trends 4.2.2. Growth factors and opportunities 4.2.3. Market size and forecast 4.2.4. Immunoassay analyzers 4.2.4.1. Market size & forecast 4.2.5. Chromatography instruments 4.2.5.1. Market size and forecast 4.2.6. Breath analyzers 4.2.6.1. Semiconductor breath analyzers 4.2.6.2. Fuel cell analyzers 4.2.6.3. Market size and forecast 4.3. RAPID TESTING DEVICES 4.3.1. Key market trends 4.3.2. Growth factors and opportunities 4.3.3. Market size and forecast 4.3.3.1. Urine testing devices 4.3.3.1.1. Market size and forecast 4.3.3.1.2. Urine testing cups (value and volume estimation) 4.3.3.1.3. U.S. 4.3.3.1.3.1.1. Market size and forecast 4.3.3.1.3.1.2. Market share analysis by competitors (2012-2016) 4.3.3.1.4. Canada 4.3.3.1.4.1.1. Market size and forecast 4.3.3.1.4.1.2. Market share analysis by competitors (2012-2016) 4.3.3.1.5. UK 4.3.3.1.5.1.1. Market size and forecast 4.3.3.1.5.1.2. Market share analysis by competitors (2012-2016) 4.3.3.1.6. Taiwan 4.3.3.1.6.1.1. Market size and forecast 4.3.3.1.6.1.2. Market share analysis by competitors (2012-2016) 4.3.3.1.7. Dip cards 4.3.3.1.8. Cassettes 4.3.3.2. Oral fluid testing devices 4.3.3.2.1. Market size and forecast 4.4. CONSUMABLES 4.4.1. Key market trends 4.4.2. Growth factors and opportunities 4.4.3. Market size and forecast 4.4.4. Assay kits 4.4.4.1. Market size and forecast 4.4.5. Sample collection cups 4.4.5.1. Market size and forecast 4.4.6. Calibrators and controls 4.4.6.1. Market size and forecast 4.4.7. Others 4.4.7.1. Market size and forecast 4.5. LABORATORY SERVICES 4.5.1. Key market trends 4.5.2. Growth factors and opportunities 4.5.3. Market size and forecast
Chapter: 5 DRUG SCREENING MARKET, BY SAMPLE TYPE 5.1. OVERVIEW 5.1.1. Market size and forecast 5.2. URINE 5.2.1. Market size and forecast 5.3. ORAL FLUID 5.3.1. Market size and forecast 5.4. BREATH 5.4.1. Market size and forecast 5.5. HAIR 5.5.1. Market size and forecast 5.6. OTHER SAMPLES (BLOOD AND SWEAT) 5.6.1. Market size and forecast
Chapter: 6 DRUG SCREENING MARKET, BY END USER 6.1. OVERVIEW 6.1.1. Market size and forecast 6.2. WORKPLACES AND SCHOOLS 6.2.1. Market size and forecast 6.3. CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES 6.3.1. Market size and forecast 6.4. DRUG TESTING LABORATORIES 6.4.1. Market size and forecast 6.5. DRUG TREATMENT CENTERS 6.5.1. Market size and forecast 6.6. HOSPITALS 6.6.1. Market size and forecast 6.7. PERSONAL USERS 6.7.1. Market size and forecast 6.8. PAIN MANAGEMENT CENTERS 6.8.1. Market size and forecast
Chapter: 7 DRUG SCREENING MARKET, BY GEOGRAPHY 7.1. OVERVIEW 7.2. NORTH AMERICA 7.2.1. Key Market Trends 7.2.2. Key growth factors and opportunities 7.2.3. Market size and forecast 7.2.3.1. U.S. market size and forecast 7.2.3.2. Canada market size and forecast 7.2.3.3. Mexico market size and forecast 7.3. EUROPE 7.3.1. Key market trends 7.3.2. Key growth factors and opportunities 7.3.3. Market size and forecast 7.3.3.1. Germany market size and forecast 7.3.3.2. UK market size and forecast 7.3.3.3. France market size and forecast 7.3.3.4. Italy market size and forecast 7.3.3.5. Rest of Europe market size and forecast 7.4. ASIA-PACIFIC 7.4.1. Key market trends 7.4.2. Key growth factors and opportunities 7.4.3. Market size and forecast 7.4.3.1. Japan market size and forecast 7.4.3.2. China market size and forecast 7.4.3.3. India market size and forecast 7.4.3.4. Australia market size and forecast 7.4.3.5. Rest of Asia-Pacific market size and forecast 7.5. LAMEA 7.5.1. Key market trends 7.5.2. Key growth factors and opportunities 7.5.3. Market size and forecast 7.5.3.1. Brazil market size and forecast 7.5.3.2. Turkey market size and forecast 7.5.3.3. South Africa market size and forecast 7.5.3.4. Rest of LAMEA market size and forecast
Chapter: 8 COMPANY PROFILES 8.1. ALERE INC. 8.1.1. Company overview 8.1.2. Company snapshot 8.1.3. Operating business segments 8.1.4. Product portfolio 8.1.5. Business performance 8.1.6. Key strategic moves and developments 8.2. DRAGERWERK AG & CO. KGAA 8.2.1. Company overview 8.2.2. Company snapshot 8.2.3. Operating business segments 8.2.4. Product portfolio 8.2.5. Business performance 8.3. ABBOTT LABORATORIES 8.3.1. Company overview 8.3.2. Company snapshot 8.3.3. Operating business segments 8.3.4. Product portfolio 8.3.5. Business performance 8.3.6. Key strategic moves and developments 8.4. BIO-RAD LABORATORIES, INC. 8.4.1. Company overview 8.4.2. Company snapshot 8.4.3. Operating business segments 8.4.4. Product portfolio 8.4.5. Business performance 8.5. DANAHER CORPORATION 8.5.1. Company overview 8.5.2. Company Snapshot 8.5.3. Operating business segments 8.5.4. Product portfolio 8.5.5. Business performance 8.5.6. Key strategic moves and developments 8.6. EXPRESS DIAGNOSTICS INTERNATIONAL INC. 8.6.1. Company overview 8.6.2. Company snapshot 8.6.3. Operating business segments 8.6.4. Key strategic moves and developments 8.7. F. HOFFMANN-LA ROCHE AG (ROCHE DIAGNOSTICS) 8.7.1. Company overview 8.7.2. Company snapshot 8.7.3. Operating business segments 8.7.4. Product portfolio 8.7.5. Business performance 8.7.6. Key strategic moves and developments 8.8. QUEST DIAGNOSTICS INCORPORATED 8.8.1. Company overview 8.8.2. Company snapshot 8.8.3. Operating business segments 8.8.4. Product portfolio 8.8.5. Business performance 8.9. SIEMENS AKTIENGESELLSCHAFT 8.9.1. Company overview 8.9.2. Company snapshot 8.9.3. Operating segments 8.9.4. Product portfolio 8.9.5. Business performance 8.9.6. Key strategic moves and developments 8.10. THERMO FISHER SCIENTIFIC INC. 8.10.1. Company overview 8.10.2. Company snapshot 8.10.3. Operating business segments 8.10.4. Product portfolio 8.10.5. Business performance 8.10.6. Key strategic moves and developments LIST OF TABLES TABLE 1. GLOBAL DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2023 ($MILLION) TABLE 2. DRUG SCREENING MARKET FOR EQUIPMENT, BY TYPE, 2016-2023 ($MILLION) TABLE 3. DRUG SCREENING MARKET FOR EQUIPMENT, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 4. DRUG SCREENING MARKET FOR IMMUNOASSAY ANALYZERS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 5. DRUG SCREENING MARKET FOR CHROMATOGRAPHY INSTRUMENTS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 6. DRUG SCREENING MARKET FOR BREATH ANALYZERS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 7. DRUG SCREENING RAPID TESTING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION) TABLE 8. DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 9. DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 10. U.S. DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS) TABLE 11. U.S.MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016) TABLE 12. CANADA DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS) TABLE 13. CANADA MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016) TABLE 14. UK DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS) TABLE 15. UK MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016) TABLE 16. TAIWAN DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS) TABLE 17. TAIWAN MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016) TABLE 18. DRUG SCREENING MARKET FOR ORAL FLUID TESTING DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 19. GLOBAL DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2016-2023 ($MILLION) TABLE 20. DRUG SCREENING MARKET FOR CONSUMABLES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 21. DRUG SCREENING MARKET FOR ASSAY KITS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 22. DRUG SCREENING MARKET FOR SAMPLE COLLECTION CUPS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 23. DRUG SCREENING MARKET FOR CALIBRATORS AND CONTROLS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 24. DRUG SCREENING MARKET FOR OTHERS CONSUMABLES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 25. DRUG SCREENING MARKET FOR LABORATORY SERVICES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 26. GLOBAL DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION) TABLE 27. DRUG SCREENING MARKET FOR URINE SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 28. DRUG SCREENING MARKET FOR ORAL FLUID SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 29. DRUG SCREENING MARKET FOR BREATH SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 30. DRUG SCREENING MARKET FOR HAIR SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 31. DRUG SCREENING MARKET FOR OTHER SAMPLES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 32. GLOBAL DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION) TABLE 33. DRUG SCREENING MARKET FOR WORKPLACE AND SCHOOLS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 34. DRUG SCREENING MARKET FOR CRIMINAL INVESTIGATION SERVICES & LAW ENFORCEMENT AGENCIES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 35. DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 36. DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 37. DRUG SCREENING MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 38. DRUG SCREENING MARKET FOR PERSONAL USERS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 39. DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 40. NORTH AMERICA DRUG SCREENING MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 41. NORTH AMERICA DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023, ($MILLION) TABLE 42. NORTH AMERICA DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023, ($MILLION) TABLE 43. NORTH AMERICA DRUG SCREENING MARKET, BY END USER, 2016-2023, ($MILLION) TABLE 44. EUROPE DRUG SCREENING MARKET, BY COUNTRY, 2016-2023, ($MILLION) TABLE 45. EUROPE DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 ($MILLION) TABLE 46. EUROPE DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION) TABLE 47. EUROPE DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION) TABLE 48. ASIA-PACIFIC DRUG SCREENING MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 49. ASIA-PACIFIC DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 ($MILLION) TABLE 50. ASIA-PACIFIC DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION) TABLE 51. ASIA-PACIFIC DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION) TABLE 52. LAMEA DRUG SCREENING MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 53. LAMEA DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 ($MILLION) TABLE 54. LAMEA DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION) TABLE 55. LAMEA DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION) TABLE 56. ALERE: COMPANY SNAPSHOT TABLE 57. ALERE: OPERATING SEGMENTS TABLE 58. ALERE: PRODUCT PORTFOLIO TABLE 59. DRAGER: COMPANY SNAPSHOT TABLE 60. DRAGER: PRODUCT CATEGORIES TABLE 61. DRAGER: PRODUCT PORTFOLIO TABLE 62. ABBOTT: COMPANY SNAPSHOT TABLE 63. ABBOTT: OPERATING SEGMENTS TABLE 64. ABBOTT: PRODUCT PORTFOLIO TABLE 65. BIO-RAD: COMPANY SNAPSHOT TABLE 66. BIO-RAD: OPERATING SEGMENTS TABLE 67. BIO-RAD: PRODUCT PORTFOLIO TABLE 68. DANAHER: COMPANY SNAPSHOT TABLE 69. DANAHER: OPERATING SEGMENTS TABLE 70. DANAHER: PRODUCT PORTFOLIO TABLE 71. EXPRESS DIAGNOSTICS: COMPANY SNAPSHOT TABLE 72. EXPRESS DIAGNOSTICS: OPERATING SEGMENTS TABLE 73. ROCHE: COMPANY SNAPSHOT TABLE 74. ROCHE: OPERATING SEGMENT TABLE 75. ROCHE: PRODUCT PORTFOLIO TABLE 76. QUEST DIAGNOSTICS: COMPANY SNAPSHOT TABLE 77. QUEST DIAGNOSTICS: OPERATING SEGMENTS TABLE 78. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO TABLE 79. SIEMENS: COMPANY SNAPSHOT TABLE 80. SEIMENS: OPERATING SEGMENTS TABLE 81. SIEMENS: PRODUCT PORTFOLIO TABLE 82. THERMO FISHER: COMPANY SNAPSHOT TABLE 83. THERMO FISHER: OPERATING SEGMENTS TABLE 84. THERMO FISHER: PRODUCT PORTFOLIO LIST OF FIGURES FIGURE 1. GLOBAL DRUG SCREENING MARKET SEGMENTATION FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL DRUG SCREENING MARKET FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE AND DISTRIBUTION FIGURE 4. TOP WINNING STRATEGIES: TYPE AND COMPANY FIGURE 5. TOP WINNING STRATEGIES: TYPE AND NATURE FIGURE 6. BARGAINING POWER OF BUYERS FIGURE 7. BARGAINING POWER OF SUPPLIERS FIGURE 8. THREAT OF NEW ENTRANTS FIGURE 9. THREAT OF SUBSTITUTION FIGURE 10. COMPETITIVE RIVALRY FIGURE 11. PATENT REGISTERED/APPROVED, BY YEAR (2010-2016) FIGURE 12. PATENT REGISTERED/APPROVED, BY REGION (2010-2016) FIGURE 13. GLOBAL DRUG SCREENING MARKET: DRIVERS & RESTRAINTS FIGURE 14. DRUG SCREENING PRODUCT AND SERVICE SEGMENTATION FIGURE 15. DRUG SCREENING SAMPLE TYPE SEGMENTATION FIGURE 16. DRUG SCREENING MARKET END USER SEGMENTATION FIGURE 17. U.S. DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 18. CANADA DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 19. MEXICO DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 20. GERMANY DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 21. UK DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 22. FRANCE DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 23. ITALY DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 24. REST OF EUROPE DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 25. JAPAN DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 26. CHINA DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 27. INDIA DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 28. AUSTRALIA DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 29. REST OF ASIA-PACIFIC DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 30. BRAZIL DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 31. TURKEY DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 32. SOUTH AFRICA DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 33. REST OF LAMEA DRUG SCREENING MARKET, 2016-2023 ($MILLION) FIGURE 34. ALERE: NET SALES, 2014-2016 ($MILLION) FIGURE 35. ALERE: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 36. ALERE: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 37. DRAGER: NET SALES, 2014-2016 ($MILLION) FIGURE 38. DRAGER: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 39. ABBOTT: NET SALES, 2014-2016 ($MILLION) FIGURE 40. ABBOTT: REVENUE BY SEGMENT, 2016 (%) FIGURE 41. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%) FIGURE 42. BIO-RAD: NET SALES, 2014-2016 ($MILLION) FIGURE 43. BIO-RAD: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 44. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 45. DANAHER: NET SALES, 2014-2016 ($MILLION) FIGURE 46. DANAHER: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 47. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 48. ROCHE: NET SALES, 2014-2016 ($MILLION) FIGURE 49. ROCHE: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 50. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 51. QUEST DIAGNOSTICS: NET SALES, 2014-2016 ($MILLION) FIGURE 52. QUEST DIAGNOSTICS: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 53. SIEMENS: NET SALES, 2014-2016 ($MILLION) FIGURE 54. SIEMENS: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 55. SIEMENS: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 56. THERMO FISHER: NET SALES, 2014-2016 ($MILLION) FIGURE 57. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 58. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

Purchase Options